With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening||Dana-Farber Cancer Institute / Stuart Orkin, MD||Innovation Grants||2012||Massachusetts|
|The role of vitamin D in hepatoblastoma formation and prevention||Brigham and Women's Hospital / Wolfram Goessling, MD/PhD||Innovation Grants||2012||Massachusetts|
|Development of the Next Generation FLT3 Inhibitors for Pediatric AML and Infant ALL||The Johns Hopkins University School of Medicine / Donald Small, MD, PhD||Innovation Grants||2012||Maryland|
|Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research||Washington University / Kimberly Johnson Ph.D.||Epidemiology Grants||2012||Missouri|
|Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database||Huntsman Cancer Institute / Joshua Schiffman, MD||Epidemiology Grants||2012||Utah|
|Childhood Leukemia in Kenya Identified Through Malaria Slide Review||Indiana University / Terry Vik||Epidemiology Grants||2012||Indiana|
|Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia||Washington University / Grant Challen, PhD||'A' Award Grants||2012||Missouri|
|A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma||Massachusetts General Hospital / Myron Ignatius, PhD||'A' Award Grants||2012||Massachusetts|
|BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia||Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD||'A' Award Grants||2012||New York|
|Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD||'A' Award Grants||2012||Washington|